161 related articles for article (PubMed ID: 8045921)
21. Biologic and clinical significance of CD7 expression in acute myeloid leukemia.
Saxena A; Sheridan DP; Card RT; McPeek AM; Mewdell CC; Skinnider LF
Am J Hematol; 1998 Aug; 58(4):278-84. PubMed ID: 9692390
[TBL] [Abstract][Full Text] [Related]
22. Biological characteristics of CD7 positive acute myelogenous leukaemia.
Eto T; Akashi K; Harada M; Shibuya T; Takamatsu Y; Teshima T; Niho Y
Br J Haematol; 1992 Nov; 82(3):508-14. PubMed ID: 1283077
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of acute myeloid leukemia and system Coulter VCS.
Bruno A; Del Poeta G; Venditti A; Stasi R; Adorno G; Aronica G; Suppo G; Di Rienzo AM; Iazzoni R; Tribalto M
Haematologica; 1994; 79(5):420-8. PubMed ID: 7843628
[TBL] [Abstract][Full Text] [Related]
24. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
25. Altered expression of CD45 isoforms in differentiation of acute myeloid leukemia.
Miyachi H; Tanaka Y; Gondo K; Kawada T; Kato S; Sasao T; Hotta T; Oshima S; Ando Y
Am J Hematol; 1999 Nov; 62(3):159-64. PubMed ID: 10539882
[TBL] [Abstract][Full Text] [Related]
26. Acute myeloid leukemia-FAB classification and its correlation with clinico-haematological features.
Hassan K; Qureshi M; Shafi S; Ikram N; Akhtar MJ
J Pak Med Assoc; 1993 Oct; 43(10):200-3. PubMed ID: 8114248
[TBL] [Abstract][Full Text] [Related]
27. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
28. Acute myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
Mesárosová A; Hrivnáková A; Babusíková O
Neoplasma; 1993; 40(6):341-5. PubMed ID: 8289964
[TBL] [Abstract][Full Text] [Related]
29. Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes.
Venditti A; Del Poeta G; Buccisano F; Tamburini A; Cox MC; Stasi R; Bruno A; Aronica G; Maffei L; Suppo G; Simone MD; Forte L; Cordero V; Postorino M; Tufilli V; Isacchi G; Masi M; Papa G; Amadori S
Blood; 1997 Jan; 89(2):621-9. PubMed ID: 9002966
[TBL] [Abstract][Full Text] [Related]
30. Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemia.
Dubosc-Marchenay N; Lacombe F; Dumain P; Marit G; Montastruc M; Belloc F; Reiffers J
Hematol Oncol; 1992; 10(5):235-49. PubMed ID: 1493908
[TBL] [Abstract][Full Text] [Related]
31. The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry.
Zelezníková T; Babusíková O
Neoplasma; 2005; 52(6):517-22. PubMed ID: 16284699
[TBL] [Abstract][Full Text] [Related]
32. Classifying acute leukemia by immunophenotyping: a combined FAB-immunologic classification of AML.
Neame PB; Soamboonsrup P; Browman GP; Meyer RM; Benger A; Wilson WE; Walker IR; Saeed N; McBride JA
Blood; 1986 Dec; 68(6):1355-62. PubMed ID: 3465377
[TBL] [Abstract][Full Text] [Related]
33. [Immunophenotypic analysis in acute leukemia].
Akashi K; Harada M
Nihon Rinsho; 1992 Jun; 50(6):1229-35. PubMed ID: 1518138
[TBL] [Abstract][Full Text] [Related]
34. Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma.
Kita K; Miwa H; Nakase K; Kawakami K; Kobayashi T; Shirakawa S; Tanaka I; Ohta C; Tsutani H; Oguma S
Blood; 1993 May; 81(9):2399-405. PubMed ID: 7683218
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia.
Paredes-Aguilera R; Romero-Guzman L; Lopez-Santiago N; Burbano-Ceron L; Camacho-Del Monte O; Nieto-Martinez S
Am J Hematol; 2001 Oct; 68(2):69-74. PubMed ID: 11559944
[TBL] [Abstract][Full Text] [Related]
36. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype.
Alsabeh R; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1997 Apr; 107(4):430-7. PubMed ID: 9124211
[TBL] [Abstract][Full Text] [Related]
37. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
38. [Relationship between immunological characteristics and prognosis in children with acute myeloid leukemia].
Gu LJ; Tie LJ; Jiang LM; Chen J; Pan C; Dong L; Chen J; Xue HL; Tang JY; Wang YP; Ye H
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):241-5. PubMed ID: 19374802
[TBL] [Abstract][Full Text] [Related]
39. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
Urbano-Ispizua A; Matutes E; Villamor N; Sierra J; Pujades A; Reverter JC; Feliu E; Cervantes F; Vives-Corrons JL; Montserrat E
Br J Haematol; 1992 Jun; 81(2):178-83. PubMed ID: 1322689
[TBL] [Abstract][Full Text] [Related]
40. Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia.
Kraguljac N; Marisavljevic D; Jankovic G; Radosevic N; Pantic M; Donfrid M; Miletic N; Boskovic D; Colovic M
Am J Clin Pathol; 2000 Jul; 114(1):29-34. PubMed ID: 10884796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
